Prevention of Relapse in Schizophrenia
Authors:
- Nina R. SchoolerNSNina R. Schooler
- Jerome LevineJLJerome Levine
- Joanne B. SevereJSJoanne B. Severe
- Benjamin BrauzerBBBenjamin Brauzer
- Alberto DiMascioADAlberto DiMascio
- Gerald L. KlermanGKGerald L. Klerman
- Vicente B. TuasonVTVicente B. Tuason
- 1 January 1980
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 37 (1) , 16-24
Abstract
From JAMA Psychiatry — Prevention of Relapse in Schizophrenia — An Evaluation of Fluphenazine DecanoateKeywords
This publication has 9 references indexed in Scilit:
- The role of depot neuroleptics in the treatment of schizophrenic patientsPsychological Medicine, 1979
- A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophreniaPsychological Medicine, 1978
- The Influence of Family and Social Factors on the Course of Psychiatric IllnessThe British Journal of Psychiatry, 1976
- A Mirror Image Out-Patient Study at a Depot Phenothiazine ClinicAustralian & New Zealand Journal of Psychiatry, 1976
- Prevention of Recidivism of Schizophrenics Treated with Fluphenazine EnanthatePsychosomatics, 1975
- Controlled Trial of Depot Fluphenazine in Out-patient SchizophrenicsThe British Journal of Psychiatry, 1974
- THE CONTRIBUTION OF FLUPHENAZINE ENANTHATE AND DECANOATE IN THE PREVENTION OF READMISSION OF SCHIZOPHRENIC PATIENTSActa Psychiatrica Scandinavica, 1971
- Severe Depressive Mood Changes Following Slow-release Intramuscular Fluphenazine InjectionBMJ, 1969
- Level of Arousal and the Subclassification of SchizophreniaArchives of General Psychiatry, 1962